The Alzheimer's Research Podcast
The Alzheimer's Research Podcast
Podcast Description
The Alzheimer's Research Podcast is a conversation-style podcast by the Alzheimer's Therapeutic Research Institute (ATRI) that provides valuable insights and information about Alzheimer's disease, cutting-edge research, and the impact of studies and trials. The podcast features in-depth discussions with ATRI researchers, scientists, study participants, and other experts in the field. Listen in to learn about the people behind the science, their roles, and work. In 2025, ATRI celebrates their 10-year anniversary and marks a “ten years closer to prevention” milestone, discussing what each guest considers to be the most significant moment in time for them and their particular subject matter area of expertise.
Podcast Insights
Content Themes
The podcast focuses on Alzheimer's disease research, clinical trials, and prevention strategies, with episodes discussing topics such as innovative treatments and key milestones in Alzheimer’s research, including personal stories from study participants and researchers.
Brought to you by the Alzheimer’s Therapeutic Research Institute (ATRI), The Alzheimer’s Research Podcast offers an inside look at the science, stories, and people driving progress in the fight against Alzheimer’s disease. Through engaging conversations with researchers, study participants, and leading experts, we explore the latest discoveries, ongoing clinical trials, and the real-world impact of groundbreaking studies.
Regulatory affairs is one of the key mechanisms that keeps clinical trials moving forward — ensuring participant consent, overseeing the review process, and helping trials occur faster. In this episode, Elizabeth Shaffer joins the podcast to discuss her work as Regulatory Affairs Manager for the Alzheimer’s Therapeutic Research Institute (ATRI) and the Alzheimer’s Clinical Trials Consortium (ACTC). She shares an overview of the consent process for participants, explains what Institutional Review Boards (IRB) are, and how they oversee research. She discusses some key advancements in the regulatory process for Alzheimer’s clinical trials throughout her career. Elizabeth also reflects on ATRI’s progress and shares some of her hopes for the future of Alzheimer’s research.
Episode Recap:
- In this episode, we’re talking with ATRI’s Regulatory Affairs Manager, Elizabeth Shaffer (0:40)
- How did you get involved with regulatory affairs? (2:27)
- What is regulatory, and how has it evolved since you started working in this field? (5:46)
- What role does the IRB play in clinical research? (8:37)
- How do you make sure you’re communicating clearly to trial participants? (9:35)
- What are you most excited about in your work today? (13:10)
- How does your work make research faster and more accessible? (17:09)
- What does the consent process look like for participants throughout a trial? (18:36)
- What keeps you motivated to do this work, and what are you most proud of? (24:49)
- What is your hope for the future of ATRI? (30:09)
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.